Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
67,185.31 +149.03 (+0.22%) CMC Crypto 200
1,371.08 -2.76 (-0.20%)
Danone S.A. (BN.PA)
| Previous close | 59.86 |
| Open | 59.98 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 59.58 - 60.12 |
| 52-week range | 50.59 - 63.80 |
| Volume | |
| Avg. volume | 1,114,501 |
| Market cap | 38.474B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 44.07 |
| EPS (TTM) | 1.36 |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | 2.10 (3.50%) |
| Ex-dividend date | 03 May 2024 |
| 1y target est | 63.50 |
GlobeNewswireDANONE: Completion by Danone of the sale of its EDP business in Russia
Press release – Paris, May 17, 2024 Completion by Danone of the sale of its EDP business in Russia Following the press release on March 22, 2024, where Danone announced that the Russian regulatory approvals required for the disposal of its EDP business in Russia to Vamin R LLC were obtained, Danone announces today it has completed this transaction. About Danone (www.danone.com) Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categ
- GlobeNewswire
Danone: Information on the total number of voting rights and shares
DANONE French Société anonyme with a capital of €169,443,282,00. Registered Office: 17, boulevard Haussmann, 75009 Paris. Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) DateTotal number of sharesTotal number of vo
- GlobeNewswire
Danone acquires Functional Formularies
Press release – Paris, May 01, 2024 Danone acquires Functional Formularies Danone announces today it has successfully completed the acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital. As part of the Renew Danone strategy, this acquisition strengthens Danone’s Medical Nutrition portfolio in the US by further expanding its enteral tube feeding ranges. Juergen Esser, Deputy CEO and CFO, said: “As a global leader in Medical Nutriti
